67 results
Page 3 of 4
10-KT
39ogo76
26 Mar 18
Annual report (with FYE transition)
12:00am
8-K
EX-1.1
ft21c29lk4lbuu07b
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
424B5
nqx1p xthw3j7z8stx
7 Oct 15
Prospectus supplement for primary offering
12:00am
D
s6bvtfy1
23 Oct 14
$12.5M in equity, sold $9M, 1 investor
12:00am
8-K
EX-10.1
imrwc
15 Oct 14
ContraVir Pharmaceuticals Closes $9.0 Million Financing to Advance Lead Shingles Candidate
12:00am
10-K
3wa7cv4qp
29 Sep 14
Annual report
12:00am
D
jssyao3dao1381t0y
22 Aug 14
$4.74M in equity, sold $4.74M, 19 investors
12:00am
10-12G/A
EX-99.1
0h0mox7cha98r216png
6 Feb 14
Registration of securities (amended)
12:00am
8-K
EX-10.1
pscm3
5 Feb 14
Entry into a Material Definitive Agreement
12:00am
10-12G/A
EX-99.1
j057n5ldjd
24 Dec 13
Registration of securities (amended)
12:00am